PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -20.80% |
| Q3 2025 | -3.73% |
| Q2 2025 | 8.63% |
| Q1 2025 | -63.84% |
| Q4 2024 | 130.74% |
| Q3 2024 | -10.84% |
| Q2 2024 | 10.07% |
| Q1 2024 | -8.79% |
| Q4 2023 | -8.64% |
| Q3 2023 | -3.77% |
| Q2 2023 | -2.00% |
| Q1 2023 | 4.40% |
| Q4 2022 | 7.50% |
| Q3 2022 | -11.12% |
| Q2 2022 | -5.31% |
| Q1 2022 | 7.58% |
| Q4 2021 | 6.23% |
| Q3 2021 | 10.19% |
| Q2 2021 | 29.04% |
| Q1 2021 | -3.38% |
| Q4 2020 | 59.47% |
| Q3 2020 | 18.76% |
| Q2 2020 | 34.26% |
| Q1 2020 | 2.60% |
| Q4 2019 | 7.18% |
| Q3 2019 | 15.47% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |